| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | +25.1% |
| Cost of Revenue | $1.1M | +5.1% |
| Gross Profit | $740K | +79.2% |
| R&D Expense | $9.8M | +5.9% |
| SG&A Expense | $10.2M | -8.7% |
| Operating Income | -$61.0M | -142.8% |
| Pre-tax Income | -$60.7M | -144.1% |
| Income Tax | $0 | — |
| Net Income | -$60.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -8.4% |
| Accounts Receivable | $1.6M | +233.3% |
| Inventory | $410K | — |
| Current Assets | $11.8M | +9.9% |
| Total Assets | $35.1M | -53.2% |
| Current Liabilities | $7.3M | +1.1% |
| Total Liabilities | $47.4M | -3.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.7M | +11.2% |
| Capital Expenditures | $516K | +83.6% |
| Investing Cash Flow | -$512K | +45.1% |
| Financing Cash Flow | $20.4M | +67.6% |
| Free Cash Flow | -$21.2M | +10.1% |
| -118.4% |
| EPS (Basic) | -$4.66 | -24.3% |
| EPS (Diluted) | -$4.66 | -24.3% |
| Stockholders' Equity |
| -$12.3M |
| -160.0% |